Clinical Trial Update: Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates the efficacy of the VIC regimen in metastatic colorectal cancer (BRAF-mutant) across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• VIC regimen

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer Metastatic | Phase 1, Phase 2 | Status: COMPLETED